Jacobs Levy Equity Management’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Buy
472,710
+173,237
+58% +$159K ﹤0.01% 858
2026
Q1
$368K Buy
299,473
+104,355
+53% +$181K ﹤0.01% 860
2025
Q4
$560K Buy
+195,118
New +$541K ﹤0.01% 780
2024
Q3
Sell
-67,359
Closed -$368K 976
2024
Q2
$368K Buy
+67,359
New +$424K ﹤0.01% 870

Other funds holding DH

Jacobs Levy Equity Management's DH Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its Definitive Healthcare (DH) stake by 58% in Q2 2026, buying an estimated $159K and bringing the position to 472,710 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #858.

Jacobs Levy Equity Management first reported a position in DH in Q2 2024 and has held it in 4 quarters since. The position peaked at $560K in Q4 2025. 100 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Jacobs Levy Equity Management held 472,710 shares of Definitive Healthcare worth $393K as of Q2 2026.
  • Jacobs Levy Equity Management bought 173,237 Definitive Healthcare shares in Q2 2026, an estimated $159K.
  • Definitive Healthcare made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #858 holding.
  • Jacobs Levy Equity Management first reported a position in Definitive Healthcare in Q2 2024 and has held it in 4 quarters since.
  • Jacobs Levy Equity Management's Definitive Healthcare position peaked at $560K in Q4 2025.
  • 100 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.